Related Experiment Video
Updated: Feb 2, 2026
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
CDK5 Functions as a Tumor Promoter in Human Lung Cancer
Jie Zeng1, Shuanshuan Xie1, Yang Liu1
1Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, PR China.
Abstract:
Cyclin-dependent kinase 5 (CDK5), an atypical member of the cyclin-dependent kinase family, plays an important role in the nervous system. Recent studies have shown that CDK5 is also associated with tumors. However, few studies have been done to investigate the mechanism underlying the connection between CDK5 and cancers. To explore the role of CDK5 in cancers by using an extensive bioinformatics data mining process. We mined the transcriptional, survival, functions and structure of CDK5 gene through databases and in vitro experiments. We found that higher CDK5 expression levels in most cancer cell lines while lower expression in liver and brain cancer cell lines. High expression of CDK5 was associated with shorter overall survival (OS) in lung cancer. In addition, high expression level of CDK5 promoted lung cancer cells proliferation and metastasis. Inhibited CDK5 decreases CAP1 phosphorylation. CDK5 may prove to be a valid target of anticancer therapies.
Insights
Cyclin-dependent kinase 5 (CDK5) is linked to various cancers, promoting tumor growth and metastasis, especially in lung cancer. Inhibiting CDK5 may offer a new anticancer therapy target.
Area of Science:
- Molecular Biology
- Oncology
- Bioinformatics
Background:
- Cyclin-dependent kinase 5 (CDK5) is crucial in the nervous system.
- Emerging evidence links CDK5 to cancer development.
- The precise mechanisms of CDK5 in tumorigenesis require further investigation.
Purpose of the Study:
- To explore the role of CDK5 in various cancers.
- To analyze CDK5's transcriptional, survival, functional, and structural aspects.
- To identify CDK5 as a potential therapeutic target in oncology.
Main Methods:
- Extensive bioinformatics data mining of CDK5.
- Analysis of CDK5 gene expression across cancer cell lines.
- In vitro experiments to assess CDK5 function.
- Correlation analysis between CDK5 expression and patient survival.
Main Results:
- CDK5 expression is elevated in most cancer cell lines, with exceptions in liver and brain cancers.
- High CDK5 expression correlates with reduced overall survival in lung cancer patients.
- Increased CDK5 promotes lung cancer cell proliferation and metastasis.
- CDK5 inhibition reduces CAP1 phosphorylation.
Conclusions:
- CDK5 plays a significant role in promoting cancer progression, particularly in lung cancer.
- CDK5's involvement in cancer warrants further study.
- Targeting CDK5 presents a promising strategy for novel anticancer therapies.
Related Concept Videos
01:47Lung Capacity
02:40The Eukaryotic Promoter Region
02:40The Eukaryotic Promoter Region
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...